SB 194 requires Louisiana state agencies to verify the U.S. citizenship or "satisfactory immigration status" of applicants for Medicaid, SNAP, and other public benefits like housing or food assistance. If verification fails after a single reasonable opportunity period, the state must refer the applicant's information to U.S. Immigration and Customs Enforcement (ICE) and terminate benefits. The bill specifies that "satisfactory immigration status" includes lawful permanent residents, Cuban/Haitian entrants, and those under Compact of Free Association agreements. Agencies must also provide monthly reports to the Secretary of State for voter list maintenance and submit annual reports to legislators on enforcement actions. This bill directly affects individuals applying for federal or state public benefits who cannot prove citizenship or qualifying immigration status.
This bill allows terminally ill patients (with a prognosis of one year or less) in Louisiana healthcare facilities to use medical marijuana under specific conditions. It requires facilities to permit use while prohibiting smoking/vaping, documenting it in medical records, and storing it securely in locked containers. Facilities must follow state guidelines but are not required to provide recommendations or include marijuana in discharge plans. The law acknowledges federal Schedule I restrictions but mandates compliance with state rules, allowing temporary suspension if federal agencies take enforcement action against such facilities.
This bill modifies an existing law regarding pregnant women in custody to clarify that funding for their care can come from nonprofit organizations or federal grants. The change is a minor amendment that adds specific sources of financial support to the current legal framework. It directly affects state agencies responsible for managing the healthcare of incarcerated pregnant women. The legislation does not alter the core requirement for providing care but expands the list of permissible funding origins.
This bill updates Louisiana's newborn hearing screening laws to modernize terminology and strengthen protections for infants with hearing loss. It establishes a formal Bill of Rights for deaf and hard-of-hearing children, ensuring they have access to adult role models and meaningful involvement in programs affecting their education. The legislation creates or updates an advisory council to oversee screening procedures, define hearing loss categories, and guide early intervention services. By clarifying definitions and expanding the legal framework, the bill aims to improve early detection and support for infants at risk of hearing disabilities.
This bill requires facilities that provide housing or temporary residence for individuals referred by judicial agencies to obtain a license from the Louisiana Department of Health before offering residential substance use disorder treatment. The law mandates that the Department of Health must inspect and certify these facilities as compliant with specific rules before they can provide such services to people referred by courts or other judicial bodies. Additionally, the bill establishes a process for filing complaints against unlicensed residential treatment facilities and clarifies that licensed medical professionals can still offer behavioral health services in a person's home. These changes aim to ensure that judicially referred individuals receive treatment only from facilities that meet state health and safety standards.
HB 193 restructures the membership of Louisiana's Sickle Cell Commission by specifying who serves on it. The bill requires the governor to appoint 13 members (with Senate confirmation), including key health officials like the Louisiana Department of Health secretary and Medicaid director, plus executive directors from seven regional sickle cell associations across the state. It repeals previous membership provisions that listed additional, less-specific roles. This is a procedural change affecting only the commission's composition, not sickle cell treatment or funding.
SB 124 clarifies that peer review records for healthcare providers and facilities in Louisiana are confidential, meaning they cannot be disclosed in court or through discovery, except when a provider's professional privileges are under review. It defines a "health system" as two or more hospitals under common ownership and permits such systems to share peer review information among their own hospitals for credentialing, quality improvement, or patient safety purposes without losing confidentiality. The bill also shields healthcare providers and institutions from liability when sharing peer review information in good faith for these specific uses. This bill directly affects hospitals, health systems, and healthcare providers who participate in or are subject to peer review processes.
SB 169 requires health insurance plans in Louisiana to cover biomarker testing for patients needing personalized medical treatment, such as cancer care guided by genetic markers. It defines "clinical utility" through specific criteria to ensure tests are covered without unnecessary hurdles. The law prevents insurers from denying coverage based on laboratory classifications or unrelated credentialing, ensuring the test itself - not the lab - is the focus of coverage. This directly affects patients seeking biomarker tests and insurers, reducing the need for repeated biopsies by mandating seamless coverage.
SB 222 streamlines Medicaid behavioral health services in Louisiana by removing unnecessary administrative barriers for providers. It prohibits requiring pre-employment reference letters (§302), eliminates most CPR/first aid certification demands for staff (§303), aligns documentation timelines with federal standards (§305), and allows physician assistants with specific experience to serve as medical directors (§307). The bill also requires the state to seek federal approval for telehealth reimbursement of psychosocial services by July 2026 (§308). These changes directly affect Medicaid behavioral health providers, aiming to reduce duplication and expand workforce flexibility while maintaining care quality.
SB 236 requires the Louisiana Department of Health to annually review Medicaid coverage for medications and treatments for chronic and rare kidney diseases, ensuring they meet patient needs. It mandates public input during these reviews and directs the department to partner with kidney disease organizations to boost education and early screening. The bill also requires an annual report to the legislature by January 15 each year, detailing review findings and recommendations. This affects Medicaid enrollees diagnosed with kidney disease in Louisiana by improving access to appropriate care and promoting early detection. The law focuses on systematic reviews and transparency, not changing Medicaid eligibility or funding.
